Aeglea BioTherapeutics, Inc.

/Aeglea BioTherapeutics, Inc.

We are a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer.

Symbol

Final Price
$9.01

Shares
4,500,000

Anticipated Date
TBD

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange